Cardiac Computed Tomography Angiography
Coronary
computed tomography angiography (CCTA) utilizes an infusion of iodine-containing contrast material and CT checking to look at the conduits that gracefully blood to the heart and decide if they have been limited. The pictures produced during a CT sweep can be reformatted to make three-dimensional (3D) pictures that might be seen on a screen, imprinted on film or by a 3D printer, or moved to electronic media. Cardiac figured tomography (CT) is an imaging procedure that utilizes X-beams to show subtleties of the corridors and veins of the heart. The pictures are utilized to decide if plaque or calcium stores are available in your veins and whether they are causing a blockage. The CT scanner has an enormous opening that a level stage or table travels through. A few people allude to this opening as the "doughnut gap." The patient lies on the table while experiencing a sweep. At the point when the machine is turned on, a X-beam tube inside the doughnut molded piece of the machine turns quickly around and the patient while the table travels through it. X-beams pass however the patient at various points and strike specific identifiers. The pictures caught during the sweep produce nitty gritty cross-sectional perspectives, or three-dimensional perspectives, of the heart and veins in a short measure of time.
High Impact List of Articles
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
A randomized, double-blind, controlled study to evaluate clinical efficacy and safety of novel filmogen osmotic treatment for pharyngitis
Monika Rousse, Hendrik Schutte, Martine Guy, Gael Clairefond, Ravi Shrivastava
Research Article: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Managing safety in early phase trials: is there a gold standard?
Anja Slikkerveer
Editorial: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Study design considerations for evaluating the efficacy and safety of pancreatic enzyme replacement therapy in patients with cystic fibrosis
Michael W Konstan, Drucy Borowitz, Nicole Mayer-Hamblett, Carlos Milla, Leslie Hendeles, Susan Murray, Richard A Kronmal, Susan Casey, Lynn M Rose, Wayne J Morgan,Bonnie W Ramsey
Clinical Trail Prospective: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Investigating the investigators: research malfeasance
Blair Henry
Editorial: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Are placebos inert or powerful? Vice versa
Beatrice A Golomb
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Distrust and minority trial participation: more than meets the eye
Raegan W Durant
Editorial: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
Relevant Topics in Clinical